Brief: Prostalund Gets CE Approval For New Treatment Platform
Feb 7 (Reuters) - ProstaLund AB PLUND.ST :
* PROSTALUND HAS RECEIVED CE APPROVAL UNDER MDR FOR ITS NEW
TREATMENT PLATFORM CORETHERM® EAGLE
Source text for Eikon: ID:nMFN51Qh1J
Further company coverage: PLUND.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ProstaLund AB
See all newsBrief: ProstaLund 9M Operating Profit SEK -14 Million
Brief: Prostalund Applies For Delisting From Nasdaq Stockholm
Brief: ProstaLund Takes Out Loan Of SEK 4 Mln From Two Largest Shareholders
Brief: ProstaLund Enters Collaboration Agreement With The XEN Group
Brief: Prostalund Enters Collaboration With Mayumana Healthcare